(Tell me in the comments #ObesityMedicine #GLP1 #WeightManagement #FDAApproval #ClinicalPharmacy #MedicationAccess #PublicHealth #HealthEquity #ThePublicHealthPharmacist To view or add a comment, sign in The FDA has granted expedited approval to Eli Lilly's new weight-loss pill, orforglipron (Foundayo), marking it as the second daily oral GLP-1 medication for obesity
Customers praise customer service reps Abby, Elijah, Olivia, Akeelha, and Drew by name for their helpfulness once they reach them
If youre tired of looking tired, the Mary & May Tranexamic Acid + Glutathione Eye Cream Special Set is the ultimate brightening treatment for your delicate eye area
Jay said the new study is one of the largest so far to show that the cardiovascular benefits of taking GLP-1 medications dont persist when people come off the drugs
Why it matters for high performers: Preserve strength & athletic ability Maintain metabolic rate Better long-term sustainability Improved overall health markers This is cutting-edge science worth understanding
PDE5 inhibitors help the mechanics